WORKING TOWARD DELIVERING A SIGNIFICANT IMPROVEMENT IN THE HEALTH AND QUALITY OF LIFE TO FUTURE GENERATIONS LIVING WITH XLHED


Edimer Pharmaceuticals was focused on the research and development of treatments for rare dermatological diseases. The company wound down operations in late 2016.


Year Invested: 2009
Location: Cambridge, Mass.

Associated Team Members

Cary Pfeffer, M.D.
Partner

Philip Reilly, M.D., J.D.
Venture Partner